By Rory McCann, Marketing Manager & Conference Producer, LSN
Early-stage startups can often feel like a family affair. Often a tight-knit group, founders and the early team work hard and closely, relying on each other in an environment with high stakes. In the case of OncoXome, family is not a metaphor, but reality for COO Auriane and her father, Dr. Erick Gamelin. OncoXome focuses on gene editing therapy through systemic delivery of off-the shelf heterologous cancer exosomes, an approach developed by Dr. Gamelin throughout his decades-long career in oncology. Together, this dynamic duo applies their unique backgrounds and skills to navigate the early-stage fundraising landscape and took home the second-place win at the Digital RESI JPM Innovator’s Pitch Challenge.
Check out a recent conversation with Auriane to learn more about OncoXome, their progress in early-stage fundraising, how they find success through diverse strengths, and where they are taking them next.
Interested in joining the Digital RESI March Innovator’s Pitch Challenge, March 22-24? Applications will close soon and are accepted on a first-come, first-served basis, so get yours in today!
Next Phase Newsletter 
Leave a Reply